- Stage
- Reported from committee
- Started in
- House
- Sponsors
- 223
- Latest action
- Sep 16, 2026
What it does
The ASAP Act would amend the Social Security Act to provide Medicare coverage for blood-based dementia screening tests that detect pre-symptomatic and early-stage Alzheimer’s disease and related dementias, effective January 1, 2028. The bill defines eligible tests as those cleared, classified, or approved by the FDA, including genomic sequencing, cell-free nucleic acid analysis, multiplex panels, and other equivalent blood or biospecimen-based tests determined appropriate by the Secretary of Health and Human Services. It affects Medicare beneficiaries by expanding preventive coverage to include these screening tools and amends payment provisions to ensure reimbursement for such tests under…
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
Where it goes next
While a bill can still move, the questions are about people and money.